Evidence map›Paper›PMID 40628874›Full record

ArticleScientific reports2025

An impact evaluation of the national prevention of mother to child HIV transmission program and MTCT associated factors in Uganda 2017-2019.

Linda Kisaakye Nabitaka, Augustina Delaney, Phoebe M Namukanja, Fred Nalugoda, Fredrick E Makumbi, Emilio Dirlikov, Lisa Nelson, Wilford Kirungi, Sam Sendagala, Rose B Nakityo and 12 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Linda Kisaakye NabitakaUganda Ministry of Health, AIDS Control Programme, Kampala, Uganda. lkisaakye@gmail.com.
Augustina DelaneyGlobal Health Center, Division of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Phoebe M NamukanjaDivision of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention (CDC), Kampala, Uganda, USA.
Fred NalugodaRakai Health Sciences Program (RHSP), Kalisizo, Uganda.
Fredrick E MakumbiRakai Health Sciences Program (RHSP), Kalisizo, Uganda.
Emilio DirlikovDivision of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention (CDC), Kampala, Uganda, USA.
Lisa NelsonDivision of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention (CDC), Kampala, Uganda, USA.
Wilford KirungiUganda Ministry of Health, AIDS Control Programme, Kampala, Uganda.
Sam SendagalaDivision of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention (CDC), Kampala, Uganda, USA.
Rose B NakityoDivision of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention (CDC), Kampala, Uganda, USA.
Jingo KasuleRakai Health Sciences Program (RHSP), Kalisizo, Uganda.
Doreen OndoUganda Ministry of Health, AIDS Control Programme, Kampala, Uganda.
Peter MudiopeUganda Ministry of Health, AIDS Control Programme, Kampala, Uganda.
Isaac SsewanyanaUganda National Health Laboratory and Diagnostic Services (UNHLDS), Kampala, Uganda.
Joel OpioDivision of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention (CDC), Kampala, Uganda, USA.
Dinh Thu-HaGlobal Health Center, Division of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Michelle R AdlerDivision of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention (CDC), Kampala, Uganda, USA.
Hilda AsiimweUS Agency for International Development (USAID), Kampala, Uganda.
Estella BirabwaUS Department of Defense, Walter Reed Institute for Army Research (DOD WRIAR), Kampala, Uganda.
Esther Nyamugisa OchoraUNICEF, Kampala, Uganda.
David SerwaddaRakai Health Sciences Program (RHSP), Kalisizo, Uganda.
Tom LutaloRakai Health Sciences Program (RHSP), Kalisizo, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Uganda is consistently one of the highest burden countries for mother-to-child transmission of HIV (MTCT). This study assessed Uganda's progress toward elimination of MTCT and factors associated with MTCT. Mother-infant pairs (MIP) were recruited at immunization clinics at randomly sampled public and private health facilities in Uganda during 2017-2019. Using a multistage sampling method, a nationally representative sample of MIP aged 4-12 weeks were recruited and followed longitudinally for 18 months or until the infant acquired HIV. Early MTCT was defined as an infant with confirmed HIV infection at study enrollment and was calculated using logistic regression to estimate adjusted odds ratios (aOR) and 95% confidence intervals (95% CI) for associated factors. Poisson regression was used to estimate incidence rate and incidence rate ratio (IRR) for infants acquiring HIV at any time during the study after enrollment (late MTCT) and associated factors. Early MTCT was 2.2% (95% CI: 1.3-3.6) and late MTCT rate was 5.2 per 1000 person-years (95% CI: 2.5-10.9). In the adjusted model, only detectable maternal HIV viral load (≥ 1,000 copies/mL) was significantly associated with early MTCT (aOR: 6.8, 95% CI: 2.3-19.9). Similarly, ever having a detectable viral load (at any visit) was significantly associated with late MTCT (IRR: 6.2, 95% CI: 1.2-31.7). Uganda's program has made large strides to eliminate MTCT. Identifying and addressing elevated maternal HIV viral load, especially during pregnancy and the early breastfeeding period could further reduce the number of new childhood infections in Uganda.

Indexed as

HIV InfectionsInfectious Disease Transmission, VerticalPregnancy Complications, InfectiousAdultFemaleHumansIncidenceInfantInfant, NewbornMaleMothersPregnancyRisk FactorsUgandaYoung AdultBreastfeedingHIVPMTCTPregnancy

Identifiers

PMID40628874
PMCPMC12238471

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.